Figure 1
Figure 1. Strategy for collection of leukemia with intact or deficient Nf1 gene for this study. Nf1+/+. MuLV indicates MuLV-infected Nf1-intact leukemia; Nf1−/+.MuLV, MuLV-infected leukemia with engineered null Nf1 allele. Nf1Evi2.MuLV, MuLV-infected leukemia with Nf1 disruption by proviral insertion into Nf1. * indicates that the leukemias were produced previously by the laboratory of Dr Camy I. Brannan (deceased) through multiple rounds of backcrossing Nf1-null mice onto the BXH-2 strain of mice.12,29 PIS indicates proviral insertion site; and CIS, common proviral insertion site.

Strategy for collection of leukemia with intact or deficient Nf1 gene for this study. Nf1+/+. MuLV indicates MuLV-infected Nf1-intact leukemia; Nf1−/+.MuLV, MuLV-infected leukemia with engineered null Nf1 allele. Nf1Evi2.MuLV, MuLV-infected leukemia with Nf1 disruption by proviral insertion into Nf1. * indicates that the leukemias were produced previously by the laboratory of Dr Camy I. Brannan (deceased) through multiple rounds of backcrossing Nf1-null mice onto the BXH-2 strain of mice.12,29  PIS indicates proviral insertion site; and CIS, common proviral insertion site.

Close Modal

or Create an Account

Close Modal
Close Modal